A European Multi-Center Breast Cancer MRI Dataset
Detecting breast cancer early is of the utmost importance to effectively treat the millions of women afflicted by breast cancer worldwide every year. Although mammography is the primary imaging modality for screening breast cancer, there is an increasing interest in adding magnetic resonance imaging (MRI) to screening programmes, particularly for women at high risk. Recent guidelines by the European Society of Breast Imaging (EUSOBI) recommended breast MRI as a supplemental screening tool for women with dense breast tissue. However, acquiring and reading MRI scans requires significantly more time from expert radiologists. This highlights the need to develop new automated methods to detect cancer accurately using MRI and Artificial Intelligence (AI), which have the potential to support radiologists in breast MRI interpretation and classification and help detect cancer earlier. For this reason, the ODELIA consortium has made this multi-centre dataset publicly available to assist in developing AI tools for the detection of breast cancer on MRI.
Code (0)
등록된 구현이 없습니다.
Similar Papers 제목 키워드 기반
Mask-Guided Multi-Channel SwinUNETR Framework for Robust MRI Classification
Breast cancer is one of the leading causes of cancer-related mortality in women, and early detection is essential for improving outcomes. Magnetic resonance imaging (MRI) is a highly sensitive tool for breast cancer dete…
Breast Cancer DetectionEnsemble LearningData AugmentationGeneralizability of PRS313 for breast cancer risk amongst non-Europeans in a Los Angeles biobank
Polygenic risk scores (PRS) summarize the combined effect of common risk variants and are associated with breast cancer risk in patients without identifiable monogenic risk factors. One of the most well-validated PRSs in…
A large-scale multicenter breast cancer DCE-MRI benchmark dataset with expert segmentations
Artificial Intelligence (AI) research in breast cancer Magnetic Resonance Imaging (MRI) faces challenges due to limited expert-labeled segmentations. To address this, we present a multicenter dataset of 1506 pre-treatmen…
BenchmarkingThe MAMA-MIA Challenge: Advancing Generalizability and Fairness in Breast MRI Tumor Segmentation and Treatment Response Prediction
Breast cancer is the most frequently diagnosed malignancy among women worldwide and a leading cause of cancer-related mortality. Dynamic contrast-enhanced magnetic resonance imaging plays a central role in tumor characte…
Tumor SegmentationA Multicentric Dataset for Training and Benchmarking Breast Cancer Segmentation in H&E Slides
Automated semantic segmentation of whole-slide images (WSIs) stained with hematoxylin and eosin (H&E) is essential for large-scale artificial intelligence-based biomarker analysis in breast cancer. However, existing publ…
Semantic Segmentation